WS #12576

From 498 msgs · 10 key-dev

Nurix finalizes $700M upfront collaboration with Roche for BTK degrader bexobrutideg, potential $2.3B milestones.

Nurix Therapeutics-Roche collaboration

Nurix finalizes $700M upfront collaboration with Roche for BTK degrader bexobrutideg, potential $2.3B milestones.

Full world state #12576 →